These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22010419)

  • 1. [Hypertension in pregnancy. ACE inhibitors and angiotensin II receptor antagonists are contraindicated because of their potential fetotoxicity].
    Partosch F; Stahlmann R
    Med Monatsschr Pharm; 2011 Oct; 34(10):358-62. PubMed ID: 22010419
    [No Abstract]   [Full Text] [Related]  

  • 2. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.
    Quan A
    Early Hum Dev; 2006 Jan; 82(1):23-8. PubMed ID: 16427219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ACE inhibition on the fetal kidney: decreased renal blood flow.
    Martin RA; Jones KL; Mendoza A; Barr M; Benirschke K
    Teratology; 1992 Oct; 46(4):317-21. PubMed ID: 1412062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor antagonist treatment during pregnancy.
    Alwan S; Polifka JE; Friedman JM
    Birth Defects Res A Clin Mol Teratol; 2005 Feb; 73(2):123-30. PubMed ID: 15669052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].
    Roger N; Popovic I; Madelenat P; Mahieu-Caputo D
    Gynecol Obstet Fertil; 2007 Jun; 35(6):556-60. PubMed ID: 17544313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A complicated role for the renin-angiotensin system during pregnancy: highlighting the importance of drug discovery.
    Darby M; Martin JN; LaMarca B
    Expert Opin Drug Saf; 2013 Nov; 12(6):857-64. PubMed ID: 23915333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme inhibitor fetopathy.
    Hegde AU; Parekji S; Ali US; Mehta KP
    Indian Pediatr; 1999 Jan; 36(1):79-82. PubMed ID: 10709127
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antihypertensive drug therapy--combination of AT1-receptor blocker and betablocker].
    Schindler C; Kosa M; Schröder J; Kirch W
    Dtsch Med Wochenschr; 2010 May; 135(3):98. PubMed ID: 20077385
    [No Abstract]   [Full Text] [Related]  

  • 9. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
    Diav-Citrin O; Shechtman S; Halberstadt Y; Finkel-Pekarsky V; Wajnberg R; Arnon J; Di Gianantonio E; Clementi M; Ornoy A
    Reprod Toxicol; 2011 May; 31(4):540-5. PubMed ID: 21338666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitors and ARBs: antihypertensive medications in CKD.
    Szromba C
    Nephrol Nurs J; 2005; 32(3):332-3. PubMed ID: 16035474
    [No Abstract]   [Full Text] [Related]  

  • 11. From the Centers for Disease Control and Prevention. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.
    JAMA; 1997 Apr; 277(15):1193-4. PubMed ID: 9103332
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines on the management of valvular heart disease.
    Aguiar-Souto P; Mirelis JG; Silva-Melchor L
    Eur Heart J; 2007 May; 28(10):1267; author reply 1267-8. PubMed ID: 17463010
    [No Abstract]   [Full Text] [Related]  

  • 13. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(11):240-2. PubMed ID: 9082178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of the renin angiotensin system in pregnancy and risk of fetal malformations].
    Lonati C; Morganti A
    Pediatr Med Chir; 2009; 31(3):137-9. PubMed ID: 19739495
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin receptor blockers and myocardial infarction: the importance of dosage.
    Sarzani R; Dessì-Fulgheri P
    J Hypertens; 2006 Aug; 24(8):1679-81; author reply 1681-2. PubMed ID: 16877973
    [No Abstract]   [Full Text] [Related]  

  • 16. Outpatient use of cardiovascular drugs during pregnancy.
    Andrade SE; Raebel MA; Brown J; Lane K; Livingston J; Boudreau D; Rolnick SJ; Roblin D; Smith DH; Dal Pan GJ; Scott PE; Platt R
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):240-7. PubMed ID: 18200619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth.
    Bos-Thompson MA; Hillaire-Buys D; Muller F; Dechaud H; Mazurier E; Boulot P; Morin D
    Ann Pharmacother; 2005 Jan; 39(1):157-61. PubMed ID: 15590878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors, an embryopathic class of drugs with unique properties: information for clinical teratology counselors.
    Brent RL; Beckman DA
    Teratology; 1991 Jun; 43(6):543-6. PubMed ID: 1882342
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interview with Prof. Peter Dominiak, Lübeck. "Risk of diabetes with antihypertensive drugs is clinically relevant" (interview by Dr. Angelika Bischoff)].
    Dominiak P
    MMW Fortschr Med; 2004 Dec; 146(51-52):51. PubMed ID: 15675248
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of antihypertensive drugs on the fetus.
    Rosenthal T; Oparil S
    J Hum Hypertens; 2002 May; 16(5):293-8. PubMed ID: 12082488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.